MOTS-c
$64.99
10 MG

In stock
Buy GHK-Cu peptide 100mg at Velora Research — a copper-bound tripeptide (glycyl-L-histidyl-L-lysine-Cu²⁺) supplied as a lyophilized research compound. Each batch is independently HPLC- and mass-spec-verified at ≥99% purity, with a downloadable Certificate of Analysis tied to the lot number. GHK-Cu peptide is widely studied in cell-culture and preclinical models for its activity in tissue-remodeling, collagen-pathway, and antioxidant research. Strictly for in vitro laboratory research — not for human, veterinary, cosmetic, or therapeutic use.
Specifications
GHK-Cu is the copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine — a small, naturally occurring sequence first isolated from human plasma by Loren Pickart in 1973. The copper ion binds at the histidine residue to form a stable Cu(II) chelate (sometimes written GHK-Cu²⁺ or [Cu²⁺-GHK]). It is one of the most extensively studied copper peptides in preclinical literature, with research interest spanning tissue-remodeling models, collagen and elastin synthesis assays, antioxidant chemistry, and follicular biology.
Velora Research supplies the GHK-Cu peptide as a 100mg lyophilized vial for in vitro and preclinical investigation by qualified laboratories and research professionals. Every batch is independently verified by a third-party analytical laboratory using high-performance liquid chromatography (HPLC) for purity and mass spectrometry for identity confirmation. The batch-specific Certificate of Analysis is published on our COAs page and linked from this product page.
GHK-Cu is a coordination complex between the tripeptide glycyl-L-histidyl-L-lysine (“GHK”) and a copper(II) ion. The peptide portion provides the binding pocket — copper coordinates with the histidine nitrogen, an amino group, and a peptide-bond nitrogen — producing a stable, water-soluble research compound. GHK occurs naturally in human plasma at concentrations that decline with age (published studies report ~200 ng/mL in adults around age 20, dropping to ~80 ng/mL by age 60), which has driven sustained research interest in the GHK-Cu peptide as a model compound for age-related cellular biology.
Across cell-culture and preclinical studies, GHK-Cu peptide has been characterized as a multi-pathway research compound. Published mechanisms of interest include:
All mechanisms above are drawn from peer-reviewed preclinical and in-vitro research. Velora Research supplies the GHK-Cu peptide solely for further investigation of these and related research questions in laboratory settings.
| Attribute | Specification |
| Research name | GHK-Cu peptide (copper peptide GHK-Cu) |
| Chemical name | Glycyl-L-histidyl-L-lysine-copper(II) complex |
| Sequence | Gly-His-Lys (tripeptide) + Cu²⁺ |
| Available size | 100mg |
| Form | Lyophilized blue-tinted powder (color due to copper coordination) |
| Purity | ≥99% (HPLC verified) |
| Molecular formula | C14H24N6O4Cu |
| Molecular weight | ~340.87 g/mol |
| CAS number | 89030-95-5 |
| Storage (lyophilized) | -20°C, sealed, dry, dark (copper-bound peptides are light-sensitive) |
| Storage (reconstituted) | 2-8°C, protected from light, single-use aliquots recommended |
| Verification | Independent third-party HPLC + mass spectrometry per batch |
| COA access | Batch-specific COA at verify.janoshik.com (linked from this page) |
Velora Research lists the GHK-Cu peptide at a single 100mg tier, sized so a single vial typically covers an entire pilot study or a multi-arm cell-culture experiment without re-ordering:
| Vial size | Price (USD) | Best for |
| 100mg | $60.00 (sale pricing periodically available) | Pilot studies, cell-culture assays, multi-arm preclinical work, antioxidant chemistry research |
Free US shipping applies on orders over $200; most orders ship within 1–2 business days. Because GHK-Cu peptide is light-sensitive, every shipment is packaged in opaque protective material to preserve copper coordination during transit.
“GHK-Cu benefits” is a common search query among researchers screening compounds for inclusion in studies. The areas of published research interest below summarize how peer-reviewed in-vitro and preclinical literature has characterized the compound. All language is research-frame — none of these are therapeutic claims, and none describe approved human-use indications.
These represent published areas of research interest only. Velora Research makes no claim that GHK-Cu peptide produces any specific outcome in humans, animals, or cosmetic applications. The compound is supplied for in vitro and preclinical research investigation only.
Five things separate Velora Research from generic peptide suppliers:
Velora’s GHK-Cu peptide ships as a lyophilized powder with a faint blue tint characteristic of copper coordination. For in vitro studies, researchers typically reconstitute with bacteriostatic water (0.9% benzyl alcohol) or, for cell-culture protocols, with sterile water or PBS at concentrations matched to the assay. A common pilot ratio for a 100mg vial is 5 mL of diluent, yielding a 20 mg/mL stock solution — adjust per your study design.
Velora Research supplies bacteriostatic water as a separate product. Please refer to the peer-reviewed literature for protocol-specific reconstitution and handling parameters.
Researchers evaluating GHK-Cu often weigh the copper-bound form against the unbound GHK tripeptide. Summary of how the two differ at the chemistry level:
| Attribute | GHK (unbound) | GHK-Cu (copper peptide) |
| Composition | Glycyl-L-histidyl-L-lysine tripeptide alone | GHK + Cu²⁺ coordination complex |
| Appearance (lyophilized) | White powder | Blue-tinted powder (copper signature) |
| Molecular weight | ~340 g/mol (peptide); ~340 g/mol total | ~340 g/mol (entire complex) |
| Functional pattern in published research | Studied as the peptide carrier; binds copper from solution | Studied as the pre-formed bioactive complex |
| Stability | More susceptible to oxidative degradation | Copper coordination contributes to peptide stability in published assays |
Both forms appear in preclinical literature. Velora supplies the copper-bound GHK-Cu peptide for studies that depend on the pre-coordinated Cu(II) complex.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. It occurs naturally in human plasma at age-dependent concentrations and is one of the most extensively studied copper peptides in preclinical research. Velora Research supplies it as a 100mg lyophilized research compound for in vitro investigation only.
Published preclinical and in-vitro studies have characterized GHK-Cu in several research areas, including copper-transport chemistry, antioxidant activity, fibroblast and extracellular-matrix research, follicular cell-culture models, and gene-expression profiling. These are areas of published research interest only — no claims are made about effects in humans, animals, or cosmetic applications. The compound is supplied for further laboratory investigation, not for therapeutic or consumer use.
Velora Research lists the GHK-Cu peptide 100mg vial at $60.00 USD (sale pricing periodically available). Free US shipping applies on orders over $200. Pricing reflects a research-grade compound with batch-specific HPLC and mass-spec verification.
Every batch is independently tested by a third-party analytical laboratory using HPLC for purity and mass spectrometry for identity confirmation, including verification of the copper coordination. The Certificate of Analysis is published on our /coas/ page and linked from the product page by batch number.
Store the lyophilized vial sealed at -20°C in a dry, dark environment. GHK-Cu is light-sensitive, so keep it protected from ambient light. Once reconstituted, refrigerate at 2-8°C protected from light and use within the stability window established by the research protocol. Avoid repeat freeze-thaw cycles.
GHK is the unbound tripeptide glycyl-L-histidyl-L-lysine. GHK-Cu is the same tripeptide pre-coordinated with a copper(II) ion. The bound form is what most published preclinical research uses, because the copper coordination is structurally and functionally relevant to the compound’s research profile. Velora Research supplies the copper-bound GHK-Cu form.
No. The GHK-Cu peptide supplied by Velora Research is strictly for in vitro and preclinical laboratory research. It is not packaged, formulated, or quality-controlled for cosmetic, topical-consumer, or therapeutic use. While GHK-Cu is used in some FDA-approved cosmetic formulations under separate manufacturer pipelines, Velora’s product is a research compound only and is not interchangeable with those formulations.
Velora Research accepts international orders for laboratory research use only. Buyers are responsible for ensuring compliance with all applicable local, state, and national regulations in their jurisdiction prior to purchasing.